Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators

Annals of Noninvasive Electrocardiology

Volumn 8, Issue 3, 2003, Pages 219-226

  Saeed, Mohammad ^a   Jin, Anna ^b   Pontone, Gregory ^b   Higgins, Steve ^c   Gold, Michael ^d   Harari, David ^e   Nunley, Steven ^e   Link, Mark S ^a   Homoud, Munther K ^a   Estes III, N A Mark ^a   Wang, Paul J ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c SCRIPPS MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^e Guidant CRM   (United States)

Author keywords

Implantable cardioverter defibrillator; Oversensing and undersensing; Ventricular arrhythmia

Indexed keywords

ACCURACY; ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; ELECTROGRAPHY; EVALUATION; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; FOLLOW UP; HEART ARRHYTHMIA; HEART FUNCTION TEST; HEART VENTRICLE; IMPEDANCE; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREVALENCE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

AGED; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC IMPEDANCE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; TEXAS; TREATMENT OUTCOME;

EID: 1542545945     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1542-474X.2003.08309.x     Document Type: Article

References (20)

1. Moss A, Hall W, Cannom D, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial. N Engl J Med 1996;335:1933-1940.
2. Zipes D, Wyse D, Friedman P, et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583;
3. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who were at risk for sudden death. N Engl J Med 2000;342:1937-1945.
4. Santini M, Ansalone G, Auriti A, et al. Indications for dual-chamber (DDD) pacing in implantable cardioverterdefibrillator patients. Am J Cardiol 1996;78:116-118.
5. Higgins S, Williams S, Pak J, et al. Indications for implantations of a dual-chamber pacemaker combined with an implantable cardioverter-defibrillator. Am J Cardiol 1998;81:1360-1362.
6. Kelly P, Mann D, Damle R, et al. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1531-1534.
7. Rosenthal M, Paskman C. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter defibrillator system. Pacing Clin Electrophysiol 1998;21:1380-1386.
8. Nunain S, Roelke M, Trouton T, et al. Limitations and late complications of third-generation automatic cardioverterdefibrillators. Circulation 1995;91:2204-2213.
9. Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports. J Cardiovasc Electrophysiol 1998;9:767-772.
10. Callans D, Hook B, Kleiman R, et al. Unique sensing errors in third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 1993;1993:1135-1140.
11. Mann D, Kelly P, Damle R, et al. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: Diagnosis using stored electrograms and correction with programming. Pacing Clin Electrophysiol 1994;17:1525-1530.
12. Peralta A, John R, Venditti F, et al. Undersensing of ventricular fibrillation in a noncommitted nonthoracotomy cardioverter defibrillator system. Pacing Clin Electrophysiol 1997;20:610-618.
13. Jung W, Manz M, Moosdorf R, et al. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a non-thoracotomy lead system. Circulation 1992;86:1217-1222.
14. Berul C, Callans D, Schwartzman D, et al. Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control. J Am Coll Cardiol 1995;25:431-436.
15. Wase A, Natale A, Dhala A, et al. Sensing failure in a tiered therapy implantable cardioverter defibrillator: Role of auto adjustable gain. Pacing Clin Electrophysiol 1995;18:1327-1330.
16. Callans D, Swarna U, Schwartzman D, et al. Post-shock sensing performance in transvenous defibrillation lead systems: Analysis of detection and redetection of ventricular fibrillation. J Cardiovasc Electrophysiol 1995;6:604-612.
17. Natale A, Sra J, Axtell K, et al. Undetected ventricular fibrillation in transvenous implantable cardioverterdefibrillators. Prospective comparison of different lead system-device combinations. Circulation 1996;93:91-98.
18. Otto L, Mann D, Kelly P, et al. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation. Pacing Clin Electrophysiol 1999;22:1550-1552.
19. Mann D, Otto L, Kelly P, et al. Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverter-defibrillators. Am J Cardiol 2000;85:1380-1382.
20. Babuty D, Fauchier L, Cosnay P. Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphragmatic muscle. Heart 1999;81:94-96.